EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:44915 - propofol
| Formula | C12H18O |
| Net Charge | 0 |
| Average Mass | 178.275 |
| Monoisotopic Mass | 178.13577 |
| SMILES | CC(C)c1cccc(C(C)C)c1O |
| InChI | InChI=1S/C12H18O/c1-8(2)10-6-5-7-11(9(3)4)12(10)13/h5-9,13H,1-4H3 |
| InChIKey | OLBCVFGFOZPWHH-UHFFFAOYSA-N |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Chemical Role: | radical scavenger A role played by a substance that can react readily with, and thereby eliminate, radicals. |
| Biological Roles: | anti-obesity agent Any substance which is used to reduce or control weight. antiviral agent A substance that destroys or inhibits replication of viruses. analgesic An agent capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms. |
| Applications: | antidepressant Antidepressants are mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. cardiovascular drug A drug that affects the rate or intensity of cardiac contraction, blood vessel diameter or blood volume. antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. anticonvulsant A drug used to prevent seizures or reduce their severity. anti-arrhythmia drug A drug used for the treatment or prevention of cardiac arrhythmias. Anti-arrhythmia drugs may affect the polarisation-repolarisation phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibres. antiemetic A drug used to prevent nausea or vomiting. An antiemetic may act by a wide range of mechanisms: it might affect the medullary control centres (the vomiting centre and the chemoreceptive trigger zone) or affect the peripheral receptors. neuroprotective agent Any compound that can be used for the treatment of neurodegenerative disorders. analgesic An agent capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms. antihypertensive agent Any drug used in the treatment of acute or chronic vascular hypertension regardless of pharmacological mechanism. hepatoprotective agent Any compound that is able to prevent damage to the liver. anti-inflammatory agent Any compound that has anti-inflammatory effects. sedative A central nervous system depressant used to induce drowsiness or sleep or to reduce psychological excitement or anxiety. vulnerary A drug used in treating and healing of wounds. ophthalmology drug Any compound used for the treatment of eye conditions or eye diseases. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| propofol (CHEBI:44915) has role analgesic (CHEBI:35480) |
| propofol (CHEBI:44915) has role anti-arrhythmia drug (CHEBI:38070) |
| propofol (CHEBI:44915) has role anti-inflammatory agent (CHEBI:67079) |
| propofol (CHEBI:44915) has role anti-obesity agent (CHEBI:74518) |
| propofol (CHEBI:44915) has role anticonvulsant (CHEBI:35623) |
| propofol (CHEBI:44915) has role antidepressant (CHEBI:35469) |
| propofol (CHEBI:44915) has role antiemetic (CHEBI:50919) |
| propofol (CHEBI:44915) has role antihypertensive agent (CHEBI:35674) |
| propofol (CHEBI:44915) has role antineoplastic agent (CHEBI:35610) |
| propofol (CHEBI:44915) has role antiviral agent (CHEBI:22587) |
| propofol (CHEBI:44915) has role cardiovascular drug (CHEBI:35554) |
| propofol (CHEBI:44915) has role hepatoprotective agent (CHEBI:62868) |
| propofol (CHEBI:44915) has role intravenous anaesthetic (CHEBI:38877) |
| propofol (CHEBI:44915) has role neuroprotective agent (CHEBI:63726) |
| propofol (CHEBI:44915) has role ophthalmology drug (CHEBI:66981) |
| propofol (CHEBI:44915) has role radical scavenger (CHEBI:48578) |
| propofol (CHEBI:44915) has role sedative (CHEBI:35717) |
| propofol (CHEBI:44915) has role vulnerary (CHEBI:73336) |
| propofol (CHEBI:44915) is a alkylbenzene (CHEBI:38976) |
| propofol (CHEBI:44915) is a organic molecular entity (CHEBI:50860) |
| propofol (CHEBI:44915) is a phenols (CHEBI:33853) |
| Incoming Relation(s) |
| 4-hydroxypropofol (CHEBI:145211) has functional parent propofol (CHEBI:44915) |
| IUPAC Name |
|---|
| 2,6-bis(propan-2-yl)phenol |
| INN | Source |
|---|---|
| propofol | KEGG DRUG |
| Synonyms | Source |
|---|---|
| 2,6-bis(1-methylethyl)phenol | ChemIDplus |
| 2,6-BIS(1-METHYLETHYL)PHENOL | PDBeChem |
| 2,6-Diisopropylphenol | KEGG COMPOUND |
| Disoprofol | ChemIDplus |
| Fresofol | ChEMBL |
| ICI 35,868 | ChEMBL |
| Brand Names | Source |
|---|---|
| Diprivan | KEGG DRUG |
| Disoprivan | DrugBank |
| Disoprofol | DrugBank |
| Propofol component of ketafol | ChEMBL |
| Rapinovet | DrugBank |
| Citations |
|---|